BABA vs LEN-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.
Lennar Corporation exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and an exceptionally clean balance sheet (Debt/Equity 0.25). While the stock is significantly undervalued relative to its Graham Number ($117.86), it is currently plagued by severe fundamental deterioration, with earnings plummeting over 50% YoY. The disconnect between strong solvency and crashing growth, coupled with a 0/100 technical trend, suggests a value trap scenario in the short term despite long-term defensive viability.
Compare Another Pair
Related Comparisons
BABA vs LEN-B: Head-to-Head Comparison
This page compares Alibaba Group Holding Limited (BABA) and Lennar Corporation (LEN-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.